CAS: 77943-39-6; (4R,5S)-(+)-4-Methyl-5-Phenyl-2-Oxazolidinone

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号6638-79-5 二甲羟胺盐酸盐 | CAS号70-07-5 美芬诺酮 | CAS号80697-94-5 (2'S,4R,5S)-3-(... | CAS号201230-82-2 carbon monoxide | CAS号37577-28-9 左旋去甲麻黄碱 | CAS号124-38-9 二氧化碳 | CAS号105-58-8 碳酸二乙酯 | CAS号321851-63-2 (4R,5S)-3-[(2S)... | CAS号77877-20-4 (4R,5S)-3-丙酰基-4... | CAS号90719-31-6 N-CROTONYL-(4R,...

合成工艺路线路线简述

    Dl-苯丙醇胺盐酸盐置于氢氧化钾,Sodium Hydroxide体系中,化学反应 6.67H,反应生成 (4R,5S)-(+)-4-甲基-5-苯基-2-恶唑啉酮
    参考文献:Erythro-Directive Reduction Of .Alpha.-Substituted Alkanones By Means Of Hydrosilanes In Acidic Media
    标题:Erythro-Directive Reduction Of .Alpha.-Substituted Alkanones By Means Of Hydrosilanes In Acidic Media
    摘要:
    DOI:10.1021/jo00258A004

    海关参考信息

    专利信息


    专利号:US-6603015-B2
    优先权日:1999-03-29
    标题:Synthesis of epothilones
    发明人:GEORG GUNDA I; NAIR SAJIV K; REIFF EMILY; TUNOORI ASHOK RAO
    权利人:UNIV KANSAS
    摘要:Commercially feasible methods for synthesizing various epothilones precursors needed for the preparation of final epothilones are provided, including techniques for the synthesis of epothilone segment A and C precursors. Segment C precursors are prepared using starting nitriles, which can alternately be oxidized to ketones and converted, or reacted to form the diol with subsequent conversion to the segment. Segment A precursors are prepared by reacting a starting enone with a chiral catalyst to give an intermediate alcohol in high enantomeric excess, followed by conversion of the alcohol to the desired Segment A precursor.

    专利号:US-6630602-B1
    优先权日:1998-04-16
    标题 :Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them
    发明人:BIALER MEIR; SPIGELSTEIN OFER; YAGEN BORIS
    权利人:YISSUM RES DEV CO
    摘要:The present invention relates to racemic propylisopropyl acetic acid and propylisopropyl acetamide and their isomers in their racemic and stereospecific forms, for use in treatment of neurological and psychotic disorders, and affective disorders and to treat pain, headaches and migraines. The isomers are of the compound formula I:wherein R1 is a methyl or ethyl group; R2 is H, methyl or an ethyl group; R3 is ethyl or a propyl group; and R4 is a hydroxyl or amide group; and the total number of carbon atoms in said compound is 8, provided that when R1 is a methyl group and R4 is an amide group, R2 and R3 are not ethyl, further provided that when R1 is an ethyl and R4 a hydroxyl group, only stereoisomers of the compound are referred to. The present invention further relates to a method for the stereoselective synthesis of the 2S and 2R stereoisomer of PID and PIA. The present invention also relates to pharmaceutical compositions containing as an active ingredient a racemic mixture or stereoisomers of the compounds of the general formula (I), which are useful for the treatment of neurological and psychotic disorders, and affective disorders and to treat pain, headaches and migraines.

    专利号:US-6969732-B2
    优先权日:1999-04-12
    标 题 :Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them
    发明人:BIALER MEIR; SPIGELSTEIN OFER; YAGEN BORIS
    权利人:YISSUM RES DEV CO
    摘要:The present invention relates to racemic propylisopropyl acetic acid and propylisopropyl acetamide and their isomers in their racemic and stereospecific forms, for use in treatment of neurological and psychotic disorders, and affective disorders and to treat pain, headaches and migraines. The isomers are of the compound formula I n n R 1 is a methyl or ethyl group; R 2 is H, methyl or an ethyl group; R 3 is ethyl or a propyl group; and R 4 is a hydroxyl or amide group,n nand the total number of carbon atoms in said compound is 8, provided that when R1 is a methyl group and R4 is an amide group, R2 and R3 are not ethyl, further provided that when R1 is an ethyl and R4 a hydroxyl group, only stereoisomers of the compound are referred to.n nn The present invention further relates to a method for the stereoselective synthesis of the 2R stereoisomer of PID and PIA. The present invention also relates to pharmaceutical compositions containing as an active ingredient a racemic mixture or stereoisomers of the compounds of the general formula (I), which are useful for the treatment of neurological and psychotic disorders, and affective disorders and to treat pain, headaches and migraines.

    专利号:US-6891059-B2
    优先权日:2000-01-27
    标题:Asymmetric synthesis of pregabalin
    发明人:BURK MARK JOSEPH; GOEL OM PRAKASH; HOEKSTRA MARVIN SIMON; MICH THOMAS FREDERICK; MULHERN THOMAS; RAMSDEN JAMES A
    权利人:WARNER LAMBERT CO
    摘要:This invention provides a method of making (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (pregabalin) or a salt thereof via an asymmetric hydrogenation synthesis. Pregabalin is useful for the treatment and prevention of seizure disorders, pain, and psychotic disorders. The invention also provides intermediates useful in the production of pregabalin.

    专利号:US-6417399-B1
    优先权日:1997-01-14
    标 题:Amelioration of neurological disorders by the administration of (2R),(3S), and/or (2S),3(S) stereoisomers of valnoctamide
    发明人:BIALER MEIR; YAGEN BORIS; SPIEGELSTEIN OFER; ROEDER MICHAEL; SCHURIG VOLKER
    权利人:YISSUM RES DEV CO
    摘要:The present invention generally relates to the individual stereoisomers of the drug valnoctamide (a mixture of four stereoisomer kinds, VCD-valmethamide or 2-ethyl-3-methyl pentanamide) useful in treatment of neurological and psychotic disorders such as different kinds of epilepsy and affective disorders, and useful as tranquilizers and to treat pain, and to pharmaceutical compositions containing, as an active ingredient, these stereoisomers. The present invention further relates to a method for stereoselective separation and quantification of the four stereoisomers from a racemic mixture of VCD or plasma of patients treated with the racemic drug. The present invention further relates to a unique method for the synthesis of the individual stereoisomers.

    专利号:US-5561227-A
    优先权日:1991-07-23
    标题:Process for the stereospecific synthesis of azetidinones
    发明人:THIRUVENGADAM TIRUVETTIPURAM K; TANN CHOU-HONG; MCALLISTER TIMOTHY L
    权利人:SCHERING CORP
    摘要:This invention provides an improved process for producing azetidinones. More particularly, this invention provides the steps of producing an azetidinone represented by the formula I ##STR1## from a carboxylic acid R 2 --D--CH 2 COOH, an aldehyde R 1 --A--CHO and an amine RNH 2 , by the steps of: (a) converting a carboxylic acid to the corresponding acid chloride; (b) deprotonating a chiral oxazolidinone and treating the resulting anion with the product of step (a); (c) enolizing the product of step (b) and condensing with an imine; and (d) cyclizing the product of step (c). Steps (c) and (d) of this process are as shown in the following reaction scheme. ##STR2##
    赤峰艾克制药科技股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.arker.com.cn
    电话: 0476-8220200👤
    📞赤峰艾克制药科技股份有限公司 ⚠️参考联系方式

    销售电话:0476-8220200
    邮箱:kykfb@arker.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州法玛化学品有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hzph.com
    电话:0571-87040515👤
    📞 杭州法玛化学品有限公司⚠️参考联系方式

    电话: 0571-87040515
    邮件:chenhk@hzph.com
    网址: http://www.hzph.com
    地址:浙江省杭州市上城区复兴路88号兴合商业中心5楼533室
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    浙江省杭州市上城区复兴路88号兴合商业中心5楼533室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北鸿鑫瑞宇精细化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hbhxry.com
    企业联系电话:15307120296;13477033894👤
    📞湖北鸿鑫瑞宇精细化工有限公司 ⚠️参考联系方式
    联系人:陈经理
    电话:15307120296;13477033894
    手机:18164064948
    传真:027-65526669
    邮箱:2016269472@qq.com
    通信地址: 武汉市东湖高新技术开发区关东园路​
    邮编: 430000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武汉市东湖高新技术开发区关东园路​
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海巍涛化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.witofly.com
    企业联系电话:021-50630626,17717886015👤
    📞上海巍涛化工有限公司 ⚠️参考联系方式
    联系人:销售部
    电话:021-50630626,17717886015
    手机:17717886015
    传真:021-50563898
    邮箱:sales@witofly.com
    通信地址: 上海市松江区沈砖公路5808号14幢5层536A室
    邮编: 200127
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市松江区沈砖公路5808号14幢5层536A室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Synthetic Studies In The Lysocellin Family Of Polyether Antibiotics. The Total Synthesis Of Ferensimycin B
    作者:David A. Evans,Richard P. Polniaszek,Keith M. Devries,Denise E. Guinn,David J. Mathre |发布日期:1991.9
    摘要:A Convergent Asymmetric Synthesis Of The Polyether Antibiotic Ferensimycin B Has Been Completed. Chiral Enolate Bond Constructions Were Employed To Establish Seven Of The 16 Stereocenters Of The Subunits 35 And 52, Which Comprise The C& And Ci&3 Portions Of Ferensimycin B. The Stereogenic Centers At C3, C4, Cg, Clo, Ci6, C,,, And Cis Were Incorporated Through Internal Asymmetric Induction, While Those

    合成参考文献


    摘要:Banert, K., Science of Synthesis Knowledge Updates, (2015) 2, 278.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知